PRECIPIO INC NPI 1841375094

NPI Details

PRECIPIO INC is a clinical medical laboratory in New Haven, CT. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PRECIPIO INC NPI is 1841375094. The provider is registered as an organization entity type.

The provider's business location address is:

4 SCIENCE PARK STE 3
NEW HAVEN, CT
ZIP 06511-962
Phone: (203) 787-7888
Fax: (203) 901-1289

The provider's authorized official is Mehmed Iljazi .
The authorized official title is Billing Manager and has the following contact phone number (203) 787-7888.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Microscopic genetic analysis of tissue, manual, each additional procedure (HCPCS:88369)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Microscopic genetic analysis of tissue, manual, initial procedure (HCPCS:88368)
• Bone marrow, smear interpretation (HCPCS:85097)
• Interpretation and report of genetic testing (HCPCS:88291)
• Tissue culture for tumor disorders of bone marrow and blood cells (HCPCS:88237)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Chromosome analysis for genetic defects, count 15-20 cells (HCPCS:88262)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Chromosome analysis for genetic defects, additional karyotypes, each study (HCPCS:88280)
• Genetic sequencing localization, each multiplex procedure (HCPCS:88366)
• Gene analysis (splicing factor [3b] subunit b1) for detection of common variants (HCPCS:81347)
• Gene analysis (additional sex combs like 1, transcriptional regulator) targeted sequence analysis (HCPCS:81176)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Gene analysis (runt related transcription factor 1) targeted sequence analysis (HCPCS:81334)
• Genetic sequencing localization, initial procedure (HCPCS:88365)
• Genetic sequencing localization, each additional procedure (HCPCS:88364)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Translocation analysis (bcr/abl1) other breakpoint (HCPCS:81208)
• Gene analysis (abl proto-oncogene 1, non-receptor tyrosine kinase) (HCPCS:81170)
• Gene rearrangement analysis (immunoglobulin heavy chain locus), variable region somatic mutation analysis (HCPCS:81263)
• Chromosome analysis for genetic defects, additional cells counted, each study (HCPCS:88285)
• Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant (HCPCS:81305)
• Chromosome analysis for genetic defects, count 45 cells for mosaicism (HCPCS:88263)
• Gene analysis (nucleophosmin) exon 12 variants (HCPCS:81310)
• Gene analysis (ccaat/enhancer binding protein [c/ebp], alpha) full gene sequence (HCPCS:81218)
• Gene analysis (fms-related tyrosine kinase 3) internal tandem duplication variants (HCPCS:81245)
• Test for detecting genes associated with blood cancer (HCPCS:81246)
• Gene analysis (isocitrate dehydrogenase 1 [nadp+], soluble) for common variants (HCPCS:81120)
• Gene analysis (isocitrate dehydrogenase 2 [nadp+], mitochondrial) for common variants (HCPCS:81121)
• Gene analysis (v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog), targeted sequence (HCPCS:81272)
• Test for detecting genes associated with blood related cancer (HCPCS:81450)

The enumeration date for this NPI number is 10/26/2006 and was last updated on 3/28/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.